Travere Therapeutics to Present Abstracts at the Society for the Study of Inborn Errors of Metabolism Annual Symposium 2023
SAN DIEGO, Aug. 24, 2023 -- Travere Therapeutics, Inc. today announced that the Company will present clinical data from the Phase 1/2 COMPOSE Study of pegtibatinase, a novel investigational enzyme...
Israel General United States Nivi Nehra Cerebrotendinous Xanthomatosis Naomi Eichenbaum Corporate Communications
Source: marketscreener.com